Peroxiredoxin 5 ameliorates obesity-induced non-alcoholic fatty liver disease through the regulation of oxidative stress and AMP-activated protein kinase signaling.
Redox Biol. 2020 Jan;28:101315. doi: 10.1016/j.redox.2019.101315. Epub 2019 Sep 3.
Redox Biol. 2020.
PMID: 31505325
Free PMC article.